Bekker, P., Keshav, S., Wei, Z., Ertl, L., Wang, Y., Lai, N., . . . Schall, T. (2007). Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease.

Bekker, P., S. Keshav, Z. Wei, L. Ertl, Y. Wang, N. Lai, J. Wright, S. Ungashe, and T. Schall. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.

Bekker, P., et al. Pharmacological Inhibition of CCR9 Is a Novel Approach in the Treatment of Inflammatory Bowel Disease. 2007.